Eric J. Hyllengren - Aug 16, 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
EVP, CFO
Signature
/s/ John Chao, Attorney-in-Fact for Eric J. Hyllengren
Stock symbol
ATRA
Transactions as of
Aug 16, 2024
Transactions value $
-$7,093
Form type
4
Date filed
8/20/2024, 06:27 PM
Previous filing
May 20, 2024
Next filing
Nov 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$6.9K -1.04K -4.03% $6.63 24.8K Aug 16, 2024 Direct F1, F2, F3
transaction ATRA Common Stock Sale -$192 -29 -0.12% $6.63 24.8K Aug 16, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
F3 This amount reflects the 1:25 reverse stock split effected by the Issuer on June 20, 2024.